CLOROX CO /DE/ financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CLOROX CO /DE/ files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	5,761	5,973	6,124	6,214	6,721	7,341	7,107	7,389	7,093	7,104
Cost of revenue	3,163	3,302	3,449	3,486	3,658	4,142	4,562	4,481	4,045	3,891
Gross profit	2,598	2,671	2,675	2,728	3,063	3,199	2,545	2,908	3,048	3,213
Research and development	141	135	132	136	145	149	132	138	126	121
Selling, general and administrative	806	810	837	856	969	1,004	954	1,183	1,167	1,124
Interest expense	88	88	85	97	99	99	106	90	90	88
Interest income	5	4	6	3	2	5	5	16	23	9
Other non-operating income	7
Pre-tax income	983	1,033	1,054	1,024	1,185	900	607	238	398	1,078
Income tax	335	330	231	204	246	181	136	77	106	254
Income from continuing operations	648	703	823	820	939
Net income to minority interests				0	0	9	9	12	12	14
Net income	648	701	823	820	939	710	462	149	280	810
EPS, basic	5.01	5.43	6.37	6.42	7.46	5.66	3.75	1.21	2.26	6.56
EPS, diluted	4.92	5.33	6.26	6.32	7.36	5.58	3.73	1.20	2.25	6.52
Shares, basic (weighted)	129	129	129	128	126	126	123	124	124	124
Shares, diluted (weighted)	132	132	132	130	128	127	124	124	125	124
Dividend per share	3.11	3.24	3.60	3.94	4.29	4.49	3.48	4.72	4.80	4.88

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	401	418	131	111	871	319	183	367	202	167
Receivables	569	565	600	631	648	604	681	688	695	821
Inventory	443	459	506	512	454	752	755	696	637	523
Other current assets	72	72	74	51	47	154	106	77	88	97
Total current assets	1,485	1,514	1,311	1,305	2,020	1,829	1,725	1,828	1,622	1,608
Property, plant and equipment	906	931	996	1,034	1,103	1,302	1,334	1,345	1,315	1,267
Lease right-of-use assets					291	332	342	346	360	333
Goodwill	1,197	1,196	1,602	1,591	1,577	1,575	1,558	1,252	1,228	1,229
Intangible assets	735	722	929	912	894	918	884	712	681	566
Other non-current assets	187	210	222	274	328	378	315	462	545	558
Total assets	4,510	4,573	5,060	5,116	6,213	6,334	6,158	5,945	5,751	5,561
Accounts payable	490	501	507	507	575	930	960	1,021	950	838
Accrued liabilities	192	162	154	158	288	219	176	262	190	179
Short-term debt	0	400	0	396	0	300	0	0	0	0
Total current liabilities	1,558	1,809	1,200	1,440	1,418	2,056	1,784	1,917	1,574	1,919
Long-term debt	1,789	1,391	2,284	2,287	2,780	2,484	2,474	2,477	2,481	2,484
Lease liabilities					278	301	314	310	334	305
Other non-current liabilities	107	113	102	780	767	834	791	825	848	351
Total liabilities	4,213	4,031	4,334	4,557	5,305	5,742	5,429	5,557	5,259	5,079
Total debt	1,789	1,791	2,284	2,287	2,780	2,784	2,474	2,477	2,481	2,484
Paid-in capital	868	928	975	1,046	1,137	1,186	1,202	1,245	1,288	1,319
Retained earnings	2,163	2,440	2,797	3,150	3,567	1,036	1,048	583	250	432
Treasury stock	-2,323	-2,442	-2,658	-3,194	-3,315	-1,396	-1,346	-1,246	-1,186	-1,404
Other comprehensive income	-570	-543	-547	-602	-640	-546	-479	-493	-155	-157
Shareholders' equity	297	542	726	559	908	411	556	220	328	321
Minority interests					0	181	173	168	164	161
Total equity	297	542	726	559	908	592	729	388	492	482
Total liabilities and equity	4,510	4,573	5,060	5,116	6,213	6,334	6,158	5,945	5,751	5,561
Shares outstanding	129	129	128	126	126	123	123	124	124	123

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	648	701	823	820	939	719	471	161	292	824
Depreciation and amortization	165	163	166	180	180	211	224	236	235	219
Stock-based compensation	45	51	53	43	50	50	52	73	74	81
Deferred income tax	5	-35	-23	-20	-2	-32	5	-149	-100	-18
Change in receivables	-52	-1	-24	-32	-27	82	-84	-13	-34	-145
Change in inventory	-45	-19	-21	-7	50	-282	-18	58	55	63
Change in payables	57	-34	-47	17	291	311	-47	157	-140	-124
Cash from operations	778	865	976	992	1,546	1,276	786	1,158	695	981
Capital expenditures	-172	-231	-194	-206	-254	-331	-251	-228	-212	-220
Acquisitions	-290	0	-681	0	0	-85	0	0
Cash from investing	-430	-205	-859	-196	-252	-452	-229	-223	-175	-94
Debt issued	0	0	891	0	492	0	1,085	0	0
Debt repaid	-300	0	-400	0	0	0	-1,405	0	0
Stock issued	180	81	70	166	176	133	35	52	23	61
Share buybacks	-254	-183	-271	-661	-248	-905	-25	0	0	-332
Dividends paid	-398	-412	-450	-490	-533	-558	-571	-583	-595	-602
Cash from financing	-316	-645	-399	-815	-523	-1,391	-689	-753	-655	-924
Exchange rate effect	-13	-1	-3	-2	-5	12	-6	0	-26	0
Net change in cash	19	14	-285	-21	766	-555	-138	182	-161	-37
Free cash flow	606	634	782	786	1,292	945	535	930	483	761
Interest paid	79	78	75	87	89	89	89	99	102	97
Income taxes paid	323	347	245	207	241	303	100	73	347	264

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $83.80 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	43.8%	Gross profit / revenue.
Pre-tax margin	14.6%	Pre-tax income / revenue.
Net margin	11.2%	Net income / revenue.
FCF margin	5.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	8.5%	Cash from operations / revenue.
Effective tax rate	22.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)	11.7%	Net income / average total assets.
R&D / revenue	1.7%	Research and development expense / revenue.
SG&A / revenue	15.7%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.9%	Capital expenditures / revenue.
D&A / revenue	3.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	0.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-0.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	1.1%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	5.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	8.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	1.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	189.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	20.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-2.9%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	189.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	20.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-2.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	41.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	7.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-8.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	57.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	12.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-10.0%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	1.7%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	11.9%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	2.6%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-2.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-16.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-18.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-3.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-3.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.84x	Current assets / current liabilities.
Quick ratio	0.59x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.38x	(Cash + short-term investments) / current liabilities.
Debt / assets	38.6%	Total debt / total assets.
Liabilities / assets	98.6%	Total liabilities / total assets.
Net debt	$1.30B	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	-$504.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	19.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.30B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.05x	Revenue / average total assets.
Fixed asset turnover	5.47x	Revenue / average property, plant and equipment.
Inventory turnover	6.46x	Cost of revenue / average inventory.
Days inventory	57 days	365 x average inventory / cost of revenue.
Receivables turnover	10.1x	Revenue / average receivables.
Days sales outstanding	36 days	365 x average receivables / revenue.
Days payables	142 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	-49 days	Days inventory + days sales outstanding - days payables.
FCF conversion	50.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	34.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$6.21	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$55.51	Revenue / diluted weighted shares.
FCF per share	$3.12	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.73	Cash from operations / diluted weighted shares.
Book value per share	-$0.55	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$10.72	Tangible book value / shares outstanding.
Cash per share	$9.82	(Cash + short-term investments) / shares outstanding.
Payout ratio	79.6%	Dividends paid / net income, when net income is positive.
Dividends / FCF	158.4%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	87.1%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$10.13B	Share price x shares outstanding.
Enterprise value	$11.43B	Market cap + total debt - cash - short-term investments.
P/E	13.4x	Market cap / net income. Only when net income is positive.
P/S	1.50x	Market cap / revenue.
P/FCF	26.7x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	17.6x	Market cap / cash from operations, when positive.
EV/Sales	1.69x	Enterprise value / revenue.
EV/FCF	30.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.7%	Free cash flow / market cap.
Earnings yield	7.5%	Net income / market cap (the inverse of P/E).
Dividend yield	5.9%	Dividends paid over the period / market cap.
Shareholder yield	9.2%	(Dividends paid + share buybacks) / market cap.
PEG	0.66x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was CLOROX CO /DE/'s revenue in fiscal 2025?

CLOROX CO /DE/ reported revenue of $7.10B for fiscal 2025, 0.2% higher than the year before.

Was CLOROX CO /DE/ profitable in fiscal 2025?

Yes. Net income was $810.0M, a net margin of 11.4%.

How much free cash flow did CLOROX CO /DE/ generate in fiscal 2025?

Cash from operations of $981.0M minus capital expenditures of $220.0M left free cash flow of $761.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CLOROX CO /DE/